Satelli et al. showed that nuclear PD-L1 levels of circulating tumor cells were significantly associated with shorter survival in metastatic colorectal cancer patients and metastatic prostate cancer patients 39. This evidence concerns the gene CD274 and metastatic prostate carcinoma.